Detalles de la búsqueda
1.
First multicenter study of modified release phosphatidylcholine "LT-02" in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses.
Am J Gastroenterol
; 109(7): 1041-51, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24796768
2.
Clinical trial: a novel high-dose 1 g mesalamine suppository (Salofalk) once daily is as efficacious as a 500-mg suppository thrice daily in active ulcerative proctitis.
Inflamm Bowel Dis
; 16(11): 1947-56, 2010 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-20310020
Resultados
1 -
2
de 2
1
Próxima >
>>